Advertisement

TheBodyPRO.com Covers CROI 2017

News

Communities Affected by HIV Must Have a Voice in Clinical Research

March 7, 2017

Look for women mentors and make use of the spaces we have created for you.

-- Morenike Ukpong-Folayan, FWACS

In an interview on behalf of IFARA at CROI 2017, Dázon Dixon Diallo spoke with Morenike Ukpong-Folayan about how women of African descent and other underserved communities are impacted by research.

One of the roles of community leaders is to translate the research presented at medical conferences into language that their communities can understand. Another is to empower their communities to demand a voice in how clinical trials are designed and who is recruited for them. This includes pushing for the inclusion of women, while considering their unique biological and cultural characteristics.

Any data presented at conferences should discuss how it might be impacted by gender differences. This is especially important because the lack of success in microbicide trials has shifted the focus to oral pre-exposure prophylaxis. That form of HIV prevention is more likely to be accessed by men. Yet, there are real biological and social differences that impact not only HIV prevention and treatment but also women's willingness to use specific methods or drugs. Women must speak up to demand more research into these differences.

Watch the video to learn more:



About the panelists:

  • Dázon Dixon Diallo, M.P.H., D.H.L., SisterLove, Atlanta, Ga.
  • Morenike Ukpong-Folayan, M.B.A., B.Ch.D., FWACS, New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria.

The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Related Stories

HIV Clinical Trials Must Enroll More Women
Community Engagement in HIV Prevention Is a Disaster Management Plan



This article was provided by TheBodyPRO.com. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.